Valor202020212022202320242025TTMGastos comerciales, generales y administrativos3.67 B3.53 B3.44 B3.5 B3.7 B3.97 B3.97 BInvestigación y desarrollo997 M967 M98 M953 M998 M1.01 B1.01 BBeneficio operativo-3.57 B1.72 B-2.1 B433 M-303 M2.16 B2.16 BTotal de ingresos no operativos-834 M-1.06 B-966 M-1.06 B-981 M-934 M-934 MGastos por intereses, netos de intereses capitalizados963 M891 M930 M1.03 B1 B916 M—Ingresos no operativos, una vez deducidos los gastos por intereses-1.8 B-1.95 B-1.9 B-2.09 B-1.98 B-1.85 B-934 MIngresos/gastos extraordinarios———————Beneficio antes de impuestos-4.27 B667 M-3.04 B-622 M-1.28 B1.24 B1.24 BParticipación en los beneficios138 M9 M21 M2 M1 M15 M15 MImpuestos-168 M211 M-638 M-7 M676 M-180 M-180 MParticipación minoritaria-109 M39 M-53 M-56 M-320 M7 M7 MOtros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas-3.99 B417 M-2.35 B-559 M-1.92 B1.41 B1.41 BOperaciones suspendidas————281 M00Beneficio neto-3.99 B417 M-2.35 B-559 M-1.64 B1.41 B1.41 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas-3.99 B417 M-2.35 B-559 M-1.64 B1.41 B1.41 BBeneficio básico por acción-3.640.38-2.12-0.5-1.451.231.23Beneficio por acción diluido-3.640.38-2.12-0.5-1.451.211.21Número medio de acciones ordinarias1.09 B1.1 B1.11 B1.12 B1.13 B1.15 B4.58 BAcciones diluidas1.09 B1.11 B1.11 B1.12 B1.13 B1.16 B4.65 BEBITDA-824 M5.06 B2.52 B4.59 B3.31 B5.37 B2.57 BEBIT-2.38 B3.73 B1.21 B3.44 B2.25 B4.33 B1.99 BCosto de los ingresos8.93 B8.28 B7.95 B8.2 B8.48 B8.32 B8.32 BOtros costes de producción——4.2 B————Amortización y depreciación (flujo de caja)1.56 B1.33 B1.31 B1.15 B1.06 B1 B581 M
Teva Pharmaceutical Industries Limited American Depositary Shar
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.